How much funding has Gibran raised?

Gibran has raised $2.6M in total funding. Their latest funding round was Seed. Key investors include Together Fund, Mercuri.

Where is Gibran headquartered?

Gibran is headquartered in London, United Kingdom. The company has a team of 1-10 people.

Gibran operates in the Foundation Models / LLMs sector. Building nature-inspired, adaptive AI systems that can learn and evolve with minimal data. Dramatically reduces the labeled data and retraining required for AI models, enabling rapid adaptation to new tasks and environments inspired by biological intelligence.

When was Gibran founded?

Gibran was founded in 2025. It is based in London, United Kingdom.

How much funding has Gibran raised?

Gibran has raised $2.6M in total funding. Key investors include Together Fund, Mercuri.

Who is the CEO of Gibran?

Govind Balakrishnan is the CEO of Gibran. The company was founded in 2025.

Where is Gibran located?

Gibran is headquartered in London, United Kingdom.

What funding stage is Gibran at?

Gibran is currently at the Seed stage.

How many employees does Gibran have?

Gibran has approximately 1-10 employees.

Gibran

Category: Foundation Models / LLMs

Building nature-inspired, adaptive AI systems that can learn and evolve with minimal data. Gibran was founded in 2025. The company is led by Govind Balakrishnan. Based in London, United Kingdom. Team size: 1-10. Total funding raised: $2.6M. Latest round: Seed. Key investors include Together Fund, Mercuri.

Founded: 2025
Headquarters: London, United Kingdom
Team size: 1-10
Total funding: $2.6M

Value proposition

Dramatically reduces the labeled data and retraining required for AI models, enabling rapid adaptation to new tasks and environments inspired by biological intelligence.

Products and solutions

Nature-inspired adaptive foundation model platform (in development), APIs and tools for enterprise integration (planned)

Unique value

Gibran's approach is modeled after biological intelligence, focusing on systems that can adapt quickly to new situations using limited prior experience or data.

Target customer

Drug discovery teams, scientific researchers, educators, and creative professionals in data-sparse domains needing adaptive, human-aligned AI.

Industries served

Drug Discovery, Scientific Research, Education, Creative Industries

Technology advantage

The core advantage is the development of 'adaptive' foundation models capable of continual learning with significantly less supervision and data than conventional AI models.

How they differentiate

Gibran builds scale-free, nature-inspired adaptive foundation models that evolve with users in data-sparse domains, vs application-specific drug-discovery tools or static large-scale LLMs.

Main competitors

Recursion Pharmaceuticals, XtalPi, Sakana AI

Key partnerships

N/A

Notable customers

N/A

Major milestones

Closed a $2.6M seed round in July 2025 led by Together Fund (with Mercuri), shortly after founding., Assembled founding team with DeepMind/evolutionary biology and Curio product pedigree.

Growth metrics

Founded 2025; ~7 employees (PitchBook); LinkedIn company size 2-10; post-seed R&D expansion.

Market positioning

Positioned as a fundamental technology provider of adaptive AI for enterprises that need resilient and flexible AI systems.

Geographic focus

Initial focus on UK/EU, with plans to target global enterprise customers.

Patents and IP

N/A

About Govind Balakrishnan

Govind Balakrishnan is a seasoned entrepreneur and product leader with a background in AI and digital media. He co-founded Curio, an AI-powered news audio platform, and served as its CEO. Prior to his entrepreneurial ventures, he worked at BBC News. His experience spans across product strategy, business management, and building AI-driven products.

More Foundation Models / LLMs companies

Official website: https://gibran.ai/